Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against ischemic neuronal damage in the brain

BMB Reports

Volumn 46, Issue 7, 2013, Pages 370-375

  Ha, Seung Cheol ^a   Reum Han, A ^a   Kim, Dae Won ^b   Kim, Eun A ^a   Kim, Duk Soo ^c   Choi, Soo Young ^b   Cho, Sung Woo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

2 cyclopropylimino 3 methyl 1,3 thiazoline hydrochloride; Antioxidative agent; Ischemia; Oxidative stress; Reactive oxygen species

Indexed keywords

2 CYCLOPROPYLIMINO 3 METHYL 1,3 THIAZOLINE HYDROCHLORIDE; 2-CYCLOPROPYLIMINO-3-METHYL-1,3-THIAZOLINE HYDROCHLORIDE; ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; BRAIN ISCHEMIA; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GERBIL; HIPPOCAMPUS; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; BRAIN ISCHEMIA; CATALASE; DISEASE MODELS, ANIMAL; GERBILLINAE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIAZOLES;

EID: 84881445054     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.7.018     Document Type: Article

References (39)

1. Oostveen, J. A., Dunn, E., Carter, D. B. and Hall, E. D. (1998) Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model. J. Cereb. Blood Flow Metab. 18, 539-547.
2. Floyd, R. A. (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4, 2587-2597.
3. Petito, C. K., Torres-Munoz, J., Roberts, B., Olarte, J. P., Nowak, Jr., T. S. and Pulsinelli, W. A. (1997) DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J. Cereb. Blood Flow. Metab. 17, 967-976.
4. Frantseva, M. V., Carlen, P. L. and Perez Velazquez, J. L. (2001) Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radic. Biol. Med. 31, 1216-1227.
5. Li, P. S., He, Q. P., Nakamura, L. and Csiszar, K. (2001) Free radical spin trap a-phenyl-N-tertbutyl-nitron inhibits caspase-3 activation and reduces brain damage following a severe forebrain ischemic injury. Free Radic. Biol. Med. 31, 1191-1197.
6. Dore, S., Otsuka, T., Mito, T., Sugo, N., Hand, T., Wu, L., Hurn, P. D., Traystman, R. J. and Andreasson, K. (2003) Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 5, 155-162.
7. Sayre, L. M., Perry, G. and Smith, M. A. (2008) Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 21, 172-188.
8. Fallarini, S., Miglio, G., Paoletti, T., Minassi, A., Amoruso, A., Bardelli, C., Brunelleschi, S. and Lombardi, G. (2009) Clovamide and rosmarinic acid induce neuroprotective effects in vitro models of neuronal death. Br. J. Pharmacol. 15, 1072-1084.
9. Beal, M. F., Hyman, B. T. and Koroshetz, W. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.
10. Trushina, E. and McMurray, C. T. (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145, 1233-1248.
11. Margaill, I., Plotkine, M. and Lerouet, D. (2005) Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39, 429-443.
12. Schreibelt, G., Horssen, J. V., Rossum, S. V., Dijkstra, C. D., Drukarch, B. and Vries, H. E. (2007) Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 56, 322-330.
13. Choi, M. M., Kim, E. A., Hahn, H. G., Nam, K. D., Yang, S. J., Choi, S. Y., Kim, T. U., Cho, S. W. and Huh, J. W. (2007) Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 239, 156-166.
14. Kim, E. A., Hahn, H. G., Kim, K. S., Kim, T. U., Choi, S. Y. and Cho, S.-W. (2010) Suppression of glutamate-induced excitotoxicity by 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride in rat glial cultures. Cell. Mol. Neurobiol. 30, 807-815.
15. Kim, E. A., Hahn, H. G., Kim, T. U., Choi, S. Y. and Cho, S.-W. (2010) Attenuation of ß-amyloid-induced neuroinflammation by KHG21834 in vivo. BMB Rep. 43, 413-418.
16. Kim, H., Son, H. J., Ha, S. C., Kim, E. A., Kim, T. U., Choi, S. Y., Ahn, J. Y. and Cho, S. W. (2011) Neuroprotective effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against oxidative stress. Cell. Mol. Neurobiol. 31, 979-984.
17. Urbani, A. and Belluzzi, O. (2000) Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur. J. Neurosci. 12, 3567-3574.
18. Heiser, V., Engemann, S., Brocker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S., Herhaus, C., Barnickel, G., Bottcher, H., Lehrach, H. and Wanker, E. E. (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc. Natl. Acad. Sci. U.S.A. 99, 16400-16406.
19. Ishiyama, T., Okada, R., Nishibe, H., Mitsumoto, H. and Nakayama, C. (2004) Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Res. 1019, 226-236.
20. Brantley, E., Antony, S., Kohlhagen, G., Meng, L. H., Agama, K., Stinson, S. F., Sausville, E. A. and Pommier, Y. (2006) Anti-tumor drug candidate 2-(4-amino-3-methyl phenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Cancer Chemother. Pharmacol. 58, 62-72.
21. Mortimer, C. G., Wells, G., Crochard, J. P., Stone, E. L., Bradshaw, T. D., Stevens, M. F. G. and Westwell, A. D. (2006) Antitumor Benzothiazoles. 26.1 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J. Med. Chem. 49, 179-185.
22. Pietrancosta, N., Moumen, A., Dono, R., Lingor, P., Planchamp, V., Lamballe, F., Bahr, M., Kraus, J. L. and Maina, F. (2006) Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism. J. Med. Chem. 49, 3645-3652.
23. Carboni, S., Hiver, A., Szyndralewiez, C., Gaillard, P., Gotteland, J. P. and Vitte, P. A. (2004) AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J. Pharmacol. Exp. Ther. 310, 25-32.
24. Small, D. L. and Buchan, A. M. (2000) Animal models. Br. Med. Bull. 56, 307-317.
25. McKracken, E., Graham, D. I., Nilsen, M., Stewart, J., Nicoll, J. A. and Horsburgh, K. (2001) 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 11, 414-421.
26. Kim, D. W., Jeong, H. J., Kang, H. W., Shin, M. J., Sohn, E. J., Kim, M. J., Ahn, E. H., An, J. J., Jang, S. H., Yoo, K. Y., Won, M. H., Kang, T. C., Hwang, I. K., Kwon, O. S., Cho, S. W., Park, J., Eum, W. S. and Choi, S. Y. (2009) Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage. Free Radic. Biol. Med. 47, 941-952.
27. Kim, D. W., Kim, D.-S., Kim, M. J., Kwon, S. W., Ahn, E. H., Jeong, H. J., Sohn, E. J., Dutta, S., Lim, S. S., Cho, S.-W., Lee, K. S., Park, J., Eum, W. S., Hwang, H. S. and Choi, S. Y. (2011) Imipramine enhances neuroprotective effect of PEP-1-Catalase against ischemic neuronal damage. BMB Rep. 44, 647-652.
28. Chan, P. H. (1996) Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129.
29. Piantadosi, C. A. and Zhang, J. (1996) Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 27, 327-331.
30. Liu, D., Smith, C. L., Barone, F. C., Ellison, J. A., Lysko, P. G., Li, K. and Simpson, I. A. (1999) Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Mol. Brain Res. 68, 29-41.
31. Vieira, H. L., Belzacq, A. S. and Haouzi, D. (2001) The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305-4316.
32. Candelario-Jalil, E., Mhadu, N. H., Al-Dalain, S. M., Martinez, G. and Leon, O. S. (2001) Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 41, 233-241.
33. Wang, Q., Sun, A. Y., Simonyi, A., Jensen, M. D., Shelat, P. B., Rottinghaus, G. E., MacDonald, R. S., Miller, D. K., Lubahn, D. E., Weisman, G. A. and Sun, G. Y. (2005) Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 82, 138-148.
34. Sharma, S. S., Dhar, A. and Kaundal, R. K. (2007) FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharmacol. Res. 55, 335-342.
35. Dringen, R. (2000) Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649-671.
36. Schulz, J. B., Lindenau, J., Seyfried, J. and Dichgans, J. (2000) Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 4904-4911.
37. Lombardi, G., Varsaldi, F., Miglio, G., Papini, M. G., Battaglia, A. and Canonico, P. L. (2002) Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress. Eur. J. Pharmacol. 457, 95-99.
38. Flohe, L. and Ginzler, W. A. (1984) Assay of glutathione peroxidase. Methods Enzymol. 105, 114-121.
39. Aebi, H. (1984) Catalase in vitro. Methods Enzymol. 105, 121-126.